Family Physicians of St. Joseph

SEPTEMBER 25, 2018

Joseph, the family medicine practice is committed to providing exceptional, affordable, patient-centered primary care in SW Michigan without reliance on insurance companies for payment of services. John Proos, with the goal of providing exceptional care to the patients of Berrien County. Joseph has succeeded in doing just that.

Family Physician 52

Family Physician Families Family Primary Care 52

Physician's Weekly

JUNE 19, 2025

Gowin and his colleagues analyzed data from 1,003 adults between 22 and 36 years of age who had functional magnetic resonance imaging (fMRI), urine toxicology, and cannabis use results collected at one academic site between 2012 and 2015 as part of the Human Connectome Project. The cohort (mean age, 28.7

Community 52

Community Healthcare Diagnosis Medical 52

FDA Law Blog

AUGUST 10, 2023

Section 704(a)(4) was added to the FDCA by the Food and Drug Administration Safety and Innovation Action (FDASIA) in July 2012. Despite FDA having the authority to conduct paper inspections since the statutory provision was added to the FDCA by FDASIA in 2012, FDA did not issue a warning letter citing Section 704(a)(4) until January 2021.

Manufacturing 52

Manufacturing Electronics IT Physicals 52

FDA Law Blog

AUGUST 18, 2024

The De Novo process provides a regulatory pathway to classify novel devices for which general controls alone or general and special controls provide reasonable assurance of safety and effectiveness for the intended use. This amendment allowed sponsors with low or moderate risk devices to proactively employ the De Novo process.

Specialization 69

Specialization Hospital Physicals Provider 69

FDA Law Blog

JANUARY 12, 2025

Sasinowski On December 5, 2024, FDA published a new draft guidance on accelerated approval providing a much needed and substantial update to its guidance on the pathway. FDAs application and use of accelerated approval has evolved dramatically since it was first developed by the Agency to help address the HIV/AIDS epidemic in the late 1980s.

Clinic 64

Clinic Relationship Provider IT 64

FDA Law Blog

FEBRUARY 29, 2024

A surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign or other measure that is thought to predict clinical benefit but is not itself a measure of clinical benefit. The use of a surrogate endpoint can considerably shorten the time required prior to receiving FDA approval. FDA-2022-E-3124 ).

Clinic 59

Clinic IT Provider Patient-Centered 59

PEMBlog

JUNE 2, 2025

Before your blood pressure rises as well, know that this PEMBlog article is here to provide an overview of the recognition and management of hypertensive emergencies. Nicardipine dosing: bolus at 30 mcg/kg/bolus (maximum 2 mg/dose), then a continuous drip at 0.5-4 4 mcg/kg/min; onset of action is less than 5 minutes.

Hypertension 75

Hypertension Management Physicals Lab Testing 75